Skip Links

 

Our businesses

We operate a diversified business model across three core businesses:

Branded

The first and largest is our Branded business, which focuses on the MENA region. In this business we manufacture and sell Branded generic pharmaceuticals – for example, we sell a generic version of GSK’s Augmentin under our own Hikma brand name – AMOCLAN. We also have 20 Branded products, many of which are still under patent, that we sell under-license from the originator.
» Find out more about our Branded business

Generics

Our second largest business is the Generic business. Here we sell un-branded generic pharmaceuticals into the US market. As this market is extremely competitive, we operate as a niche player, selling a broad mix of both high and low volume products.
» Find out more about our Generic business

Injectables

Our newest business is the Injectable business. Here we manufacture and sell generic injectable pharmaceuticals as well as some branded injectable products under-licence. This business is geographically diverse with sales into US, MENA and Europe.
» Find out more about our Injectable business

Share price

13 Oct 2008

318.75p (+3.16%)